BMO Capital Markets initiated coverage on Precision BioSciences with a new price target

6/17/22 7:26:31 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

BMO Capital Markets initiated coverage of Precision BioSciences with a rating of Outperform and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DTIL

Date	Price Target	Rating	Analyst
1/10/2025	$34.00	Market Perform → Outperform	BMO Capital Markets
4/30/2024	$19.00	Buy	Guggenheim
6/17/2022	$7.00	Outperform	BMO Capital Markets
6/9/2022		Outperform → Mkt Perform	William Blair
9/10/2021	$23.00 → $26.00	Buy	Stifel